Increase in the adoption of optogenetics in the behavioral and neuroscience, technological advancements in optogenetics, growth in ultrafast laser tool technology are the key factors driving the growth of optogenetics market. Moreover, rise in the number of research laboratories adopting optogenetics technology around the globe and development in the genetic engineering research expected to propel the optogenetics market over the forecast period.
A sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-optogenetics-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
Based on the product type, optogenetics market is segmented into the following:
• Sensors
o Genetically encoded calcium indicators
o pH sensors
o Chloride sensors
o Neurotransmitter release sensors
o Voltage-sensitive fluorescent proteins
• Actuators
o Halorhodopsin
o Archaerhodopsin
o Channelrhodopsin
o Others
• Light equipment
o LEDs
o Laser
o Others
Based on the technique, optogenetics market is segmented into:
• Viral vectors
• Transgenic animals
• Cre-Dependant Expression system
Based on the application, optogenetics market is segmented into:
• Neuroscience
• Behavioural science
• Cardiovascular diseases
• Retinal disease treatment
• Others
Based on end user, optogenetics market is segmented into the following:
• Pharmaceutical & Biopharmaceutical companies
• Biotechnology companies
• Academic research institutes
To view TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-optogenetics-market/#ulp-c654SbFYO64MsOhu[/URL]
Global optogenetics market is growing at a significant CAGR owing to rise in the adoption of optogenetics technology in neuroscience and behavioral science. Innovation of newer technologies for various diseases such as obesity and retinal diseases on optogenetics platform might fuel the optogenetics market growth in near future. For instance, in August 2015, Boehringer Ingelheim and Circuit therapeutic has collaborated to develop the novel medicines for obesity on optogenetics technology platform. Acquisitions and mergers, collaborations, technological advancements, and fund raising are the strategies adopted by the companies for increasing their revenue in optogenetics market. For instance, in November 2015, RetroSense Therapeutics secured US$ 6Mn Series B financing from various organizations for the clinical development of RST-001 for the treatment of Retinitis pigmentosa. Moreover, in November 2016, Bruker targeted on optogenetics market by commercializing NeuraLight 3D an optical module for stimulating and imaging the multiple neurons.
Need more information about this report @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-optogenetics-market/#ulp-14mlyhjMGhVjZqa3[/URL]
Some of the players in optogenetics market are Coherent, Inc. (U.S.), Noldus Information technology (Netherlands), Thorlabs, Inc. (U.S.), Bruker (U.S.), Laserglow Technologies (Canada), Regenexbio, Inc. (U.S.), GenSight Biologics S.A. (France), Jackson Laboratory (U.S.), Applied Genetic Technologies Corporation (U.S.), and Circuit Therapeutics, Inc. (U.S.) to name a few.
Email: sales@precisionbusinessinsights.com
Toll Free(US): +1-866-598-1553
Get access to full summary @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-optogenetics-market/[/URL]